Younger Phenotype

Younger Phenotype provides services and products to help people to increase their healthspan by 15 years; seeks $2.35M to increase capacity of our proof-of-concept Younger System™ to serve thousands.

Proof of concept is achieved. We continue to serve a few long-term customers. We repeatedly receive requests from prospective customers, although we do not currently have the capacity to take on additional customers. Based upon this early market response, we do not anticipate any difficulties attracting new customers, once an automated system is in place.

In addition, through our website, we are currently selling our CopperUp! with AcheRelief OTC topical analgesic product directly to consumers. Many customers report restoration of function, including healing of injuries and osteoarthritis.

Our healthcare system, over the long term, is woefully inadequate. There is no plan. We inevitably and prematurely succumb to the devastating diseases of aging. This is because doctors only consider age as a risk-factor. The healthcare system is not focused on treating the process of aging, itself.

The bottom line: when it comes to the process of aging, we are all alone.

Aging is the major source of our staggering healthcare costs. There is no doubt that if we can slow the pace of aging, the onset of age-related disease and disability will be delayed, thus dramatically reducing costs.

The individual employs the Younger System to measure their biological function on a daily basis. Based upon feedback from the System, the individual makes lifestyle adjustments and employs appropriate medical interventions under a doctor’s guidance. We do this because when biological function falls below a certain level, disease kicks in.

The Younger System includes: proprietary algorithms, a mobile app, 5-10 devices and home based tests, twice a year visits to our Longevity Center™, a physician advice network, a scientific/medical team + AI, supporting products, supporting environment.

Direct to Consumer: Our primary focus will be on delivering aging management services directly to individuals, employing a subscription model. Additional revenue will be obtained by offering products (our own and third-party), which are curated for individual needs.

In addition, we have identified the following B2B channels: concierge medical services, health insurance, and anti-aging drug development. We have a portfolio of products in various stages of development. We are currently in licensing negotiations with a marketing and manufacturing concern with distribution channels.